CIBC Private Wealth Group’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $238M | Sell |
585,794
-15,961
| -3% | -$6.47M | 0.42% | 67 |
|
|
2025
Q1 | $252M | Sell |
601,755
-974
| -0.2% | -$408K | 0.53% | 53 |
|
|
2024
Q4 | $328M | Sell |
602,729
-18,187
| -3% | -$9.91M | 0.6% | 44 |
|
|
2024
Q3 | $384M | Sell |
620,916
-5,652
| -0.9% | -$3.5M | 0.69% | 34 |
|
|
2024
Q2 | $336M | Sell |
626,568
-8,491
| -1% | -$4.55M | 0.63% | 39 |
|
|
2024
Q1 | $367M | Sell |
635,059
-7,842
| -1% | -$4.53M | 0.72% | 30 |
|
|
2023
Q4 | $341M | Sell |
642,901
-18,252
| -3% | -$9.69M | 0.72% | 32 |
|
|
2023
Q3 | $335M | Sell |
661,153
-21,251
| -3% | -$10.8M | 0.79% | 30 |
|
|
2023
Q2 | $356M | Sell |
682,404
-11,165
| -2% | -$5.83M | 0.78% | 30 |
|
|
2023
Q1 | $64.3M | Sell |
693,569
-8,428
| -1% | -$781K | 0.14% | 149 |
|
|
2022
Q4 | $354M | Buy |
701,997
+31,233
| +5% | +$15.7M | 1.19% | 20 |
|
|
2022
Q3 | $340M | Buy |
670,764
+10,395
| +2% | +$5.27M | 0.92% | 27 |
|
|
2022
Q2 | $359M | Sell |
660,369
-64
| -0% | -$34.8K | 0.93% | 24 |
|
|
2022
Q1 | $390M | Buy |
660,433
+2,280
| +0.3% | +$1.35M | 0.85% | 27 |
|
|
2021
Q4 | $439M | Buy |
658,153
+7,675
| +1% | +$5.12M | 0.91% | 23 |
|
|
2021
Q3 | $372M | Buy |
650,478
+2,536
| +0.4% | +$1.45M | 0.86% | 27 |
|
|
2021
Q2 | $327M | Sell |
647,942
-102,551
| -14% | -$51.7M | 0.75% | 31 |
|
|
2021
Q1 | $343M | Sell |
750,493
-63,924
| -8% | -$29.2M | 0.86% | 26 |
|
|
2020
Q4 | $379M | Sell |
814,417
-293,303
| -26% | -$137M | 1% | 21 |
|
|
2020
Q3 | $489M | Buy |
1,107,720
+427,229
| +63% | +$189M | 1.5% | 7 |
|
|
2020
Q2 | $247M | Sell |
680,491
-338,893
| -33% | -$123M | 1.2% | 19 |
|
|
2020
Q1 | $289M | Sell |
1,019,384
-10,960
| -1% | -$3.11M | 1.24% | 15 |
|
|
2019
Q4 | $335M | Buy |
1,030,344
+282
| +0% | +$91.6K | 1.09% | 16 |
|
|
2019
Q3 | $300M | Sell |
1,030,062
-4,901
| -0.5% | -$1.43M | 1.06% | 17 |
|
|
2019
Q2 | $304M | Buy |
1,034,963
+91,414
| +10% | +$26.8M | 1.07% | 18 |
|
|
2019
Q1 | $258M | Buy |
943,549
+8,504
| +0.9% | +$2.33M | 1% | 19 |
|
|
2018
Q4 | $209M | Buy |
935,045
+12,983
| +1% | +$2.91M | 0.93% | 22 |
|
|
2018
Q3 | $225M | Buy |
922,062
+3,031
| +0.3% | +$740K | 0.85% | 24 |
|
|
2018
Q2 | $190M | Buy |
919,031
+17,336
| +2% | +$3.59M | 0.78% | 27 |
|
|
2018
Q1 | $186M | Buy |
901,695
+28,391
| +3% | +$5.86M | 0.81% | 26 |
|
|
2017
Q4 | $166M | Buy |
873,304
+162,532
| +23% | +$30.9M | 0.7% | 34 |
|
|
2017
Q3 | $134M | Buy |
710,772
+144,924
| +26% | +$27.4M | 0.61% | 45 |
|
|
2017
Q2 | $98.7M | Buy |
565,848
+1,472
| +0.3% | +$257K | 0.62% | 53 |
|
|
2017
Q1 | $86.7M | Buy |
564,376
+1,563
| +0.3% | +$240K | 0.54% | 63 |
|
|
2016
Q4 | $79.4M | Buy |
562,813
+14,405
| +3% | +$2.03M | 0.53% | 64 |
|
|
2016
Q3 | $87.2M | Buy |
548,408
+10,652
| +2% | +$1.69M | 0.61% | 55 |
|
|
2016
Q2 | $79.5M | Buy |
537,756
+10,340
| +2% | +$1.53M | 0.58% | 60 |
|
|
2016
Q1 | $74.7M | Buy |
527,416
+204,117
| +63% | +$28.9M | 0.58% | 60 |
|
|
2015
Q4 | $45.9M | Buy |
323,299
+10,131
| +3% | +$1.44M | 0.36% | 81 |
|
|
2015
Q3 | $38.3M | Buy |
313,168
+281,484
| +888% | +$34.4M | 0.32% | 86 |
|
|
2015
Q2 | $4.11M | Buy |
31,684
+2,170
| +7% | +$282K | 0.03% | 308 |
|
|
2015
Q1 | $3.97M | Buy |
29,514
+511
| +2% | +$68.6K | 0.03% | 311 |
|
|
2014
Q4 | $3.63M | Sell |
29,003
-747
| -3% | -$93.6K | 0.03% | 311 |
|
|
2014
Q3 | $3.62M | Buy |
29,750
+980
| +3% | +$119K | 0.03% | 313 |
|
|
2014
Q2 | $3.4M | Buy |
28,770
+6,850
| +31% | +$809K | 0.03% | 314 |
|
|
2014
Q1 | $2.68M | Buy |
+21,920
| New | +$2.68M | 0.02% | 334 |
|